Your browser doesn't support javascript.
loading
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
Romano, Michela; Della Porta, Matteo Giovanni; Gallì, Anna; Panini, Nicolò; Licandro, Simonetta Andrea; Bello, Ezia; Craparotta, Ilaria; Rosti, Vittorio; Bonetti, Elisa; Tancredi, Richard; Rossi, Marianna; Mannarino, Laura; Marchini, Sergio; Porcu, Luca; Galmarini, Carlos M; Zambelli, Alberto; Zecca, Marco; Locatelli, Franco; Cazzola, Mario; Biondi, Andrea; Rambaldi, Alessandro; Allavena, Paola; Erba, Eugenio; D'Incalci, Maurizio.
Afiliação
  • Romano M; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Della Porta MG; Department of Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Gallì A; Department of Internal Medicine, University of Pavia, Pavia, Italy.
  • Panini N; Department of Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Licandro SA; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Bello E; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Craparotta I; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Rosti V; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Bonetti E; IRCCS Policlinico S. Matteo Foundation, Center for the Study of Myelofibrosis, Pavia, Italy.
  • Tancredi R; IRCCS Policlinico S. Matteo Foundation, Center for the Study of Myelofibrosis, Pavia, Italy.
  • Rossi M; Division of Clinical Oncology, IRCCS Fondazione S. Maugeri, Pavia, Italy.
  • Mannarino L; Department of Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Marchini S; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Porcu L; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Galmarini CM; Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy.
  • Zambelli A; Oncology Unit, PharmaMar SAU Colmenar Viejo, Madrid, Spain.
  • Zecca M; Medical Oncology Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Locatelli F; Department of Pediatric Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cazzola M; Department of Pediatric Hematology-Oncology, IRCCS, Bambino Gesù Children's Hospital, Roma, Italy.
  • Biondi A; Department of Pediatric Science, University of Pavia, Pavia, Italy.
  • Rambaldi A; Department of Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Allavena P; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Erba E; Clinica Pediatrica, Università di Milano, Ospedale San Gerardo, Monza, Italy.
  • D'Incalci M; Hematology and Bone Marrow Transplantation Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Br J Cancer ; 116(3): 335-343, 2017 01.
Article em En | MEDLINE | ID: mdl-28072764

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Antineoplásicos Alquilantes / Tetra-Hidroisoquinolinas / Dioxóis / Leucemia Mielomonocítica Juvenil Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Antineoplásicos Alquilantes / Tetra-Hidroisoquinolinas / Dioxóis / Leucemia Mielomonocítica Juvenil Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália